The FDA has accepted for review Merck’s (NYSE:MRK) supplemental marketing application seeking approval to use combo antibiotic Recarbrio (imipenem, cilastatin and relebactam) to treat adult patients with hospital-acquired bacterial pneumonia and …
See Original Article

The Wuhan coronavirus epidemic has been a real downer for industries with customers in China or supply chains that run through it. Nobody knows just how serious this public health emergency will become, but we can be sure the pharmaceutical industry …
See Original Article

Take a deep breath. If I had not already realized that U.S. investors were becoming more concerned in their cognizance of global realities as they raced for the proverbial exits late in the Friday session, their aggregate awareness of current events was indeed …
See Original Article

People might drink beer (or any alcoholic beverage) for any number of reasons. One reason (hopefully near the top of the list) is that they enjoy the flavor. While some brews are so-called “acquired tastes,” in the end, it is hoped that people drinking them …
See Original Article

In 2020 marketing resolutions should focus on addressing privacy regulations, such as California Consumer Privacy Act (CCPA), creating a single view of the customer, and leveraging artificial intelligence and machine learning to be more responsive (or …
See Original Article